Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a plus ribavirin in relapsed HIV/HCV coinfected patients
2005-001192-34Phase 4Active
- Sponsor
- Vicente Soriano
- Start
- Oct 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon alfa and ribavirin in hepatitis C virus infection and human immunodeficiency virus infection (HIV), sponsored by Vicente Soriano. Primary endpoint: Sustained virologic response at week 72. Started Oct 2005; status: active.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-001192-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001192-34.